Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Pramipexole 0.25 mg Tablet bulk supplier for pharma manufacturers

Pramipexole 0.25 Mg Tablet Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: ER tab: 0.375 mg, 0.75 mg, 1.5 mg, 3 mg, 4.5 mg; IR Tab: 0.125 mg, 0.25 mg, 0.5 mg, 0.75 mg, 1 mg, 1.5 mg

Reference Brands: Mirapex®(US), Sifrol® (EU)

Category: Antipsychotropic Drugs

Pramipexole, a dopamine agonist for Parkinson’s and RLS, is available as 0.125–4.5 mg tablets. Brands include Mirapex® and Sifrol®. Pharma B2B platforms provide bulk access to GMP-certified Pramipexole with global regulatory compliance and consistent supply for hospitals, neurology practices, and pharmaceutical distributors.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Pramipexole is a dopamine agonist used in the treatment of Parkinson’s disease and restless legs syndrome (RLS). It is available in both immediate- and extended-release oral tablet forms with strengths ranging from 0.125 mg to 4.5 mg. Marketed under brands like Mirapex® in the US and Sifrol® in the EU, Pramipexole helps improve motor function and reduce symptoms in neurological disorders. Pharma B2B suppliers offer bulk procurement of Pramipexole from GMP-certified manufacturers, ensuring quality, regulatory compliance, and efficient global supply. Ideal for pharmacies, distributors, and hospital procurement across neurology and chronic care specialties.

Pramipexole 0.25 Mg Tablet — third party manufacturing & bulk supply

Pramipexole 0.25 Mg Tablet is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Pramipexole 0.25 Mg Tablet is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Pramipexole 0.25 Mg Tablet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Pramipexole 0.25 Mg Tablet →
Back to Listing

Frequently Asked Questions

Pramipexole is used for the treatment of Parkinson’s disease and restless legs syndrome (RLS). It helps improve motor symptoms such as stiffness, tremor, and impaired movement by stimulating dopamine receptors in the brain.

Pramipexole is a synthetic dopamine agonist. The complete generic name is pramipexole dihydrochloride monohydrate, which is chemically synthesized and not derived from any biological source.

Pramipexole is marketed under trade names such as Mirapex and Sifrol in different global markets.

The original branded versions of pramipexole were developed by Boehringer Ingelheim. Today, it is manufactured by multiple generic pharmaceutical companies worldwide.

The generic name of Pramipexole is pramipexole dihydrochloride monohydrate.

The commonly known brand names of Pramipexole include Mirapex and Sifrol.

Pramipexole is manufactured in various countries including India, the USA, and several European countries by approved pharmaceutical manufacturers.

Related Products

Levodopa + Carbidopa

Strength:
IR: 100 mg/25 mg , 250 mg/25 mg; ER: 200 mg/50 mg

Form: Tablets

Reference Brands: Sinemet®(US & EU); Rytary®, Parcopa®, Duodopa®

View Details
Cabergoline

Strength:
0.25 mg, 0.5 mg

Form: Tablets

Reference Brands: Dostinex®, Cabaser®

View Details
Chlordiazepoxide Capsule

Strength:
5 mg, 10 mg, 25 mg

Form: Capsules

Reference Brands: Librium®(US); Tropium®, Libritabs®(EU)

View Details
Clobazam

Strength:
5 mg, 10 mg, 20 mg

Form: Injectable form (primarily outside the US)

Reference Brands: Onfi®. Sympazan®(US); Frisium®(EU)

View Details
Asenapine Maleate

Strength:
5 mg, 10 mg

Form: Tablets

Reference Brands: Saphris (USA)

View Details
Quazepam

Strength:
7.5 mg, 15 mg, 30 mg

Form: Capsules

Reference Brands: Doral (USA/EU)

View Details
Flurazepam Hydrochloride

Strength:
15 mg, 30 mg

Form: Capsules

Reference Brands: Dalmane (USA)

View Details
Fosamprenavir Calcium

Strength:
700 mg , 50 mg/mL

Form: Tablets / Oral suspension

Reference Brands: Lexiva (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.